… survival in glioma patients (multivariate HR = 1.16, CI = 0.57–2.34). For colorectal cancer, we
found that post-diagnosis tricyclic … Once again, when 3 months post-diagnosis are used to …

… of antidepressants on the overall survival of the studied cohort of lung cancer patients [129]. …
TCAs translated to improved survival in patients with colorectal cancer or glioma showed no …

… Selective serotonin reuptake inhibitors (adjusted OR=1.00, 95% CI=0.94–1.06), tricyclic
antidepressants, serotonin-norepinephrine reuptake inhibitors, and serotonin antagonist and …

… cancers studied were; tricyclic antidepressants and both incidence and survival in a number
of cancer types, particularly glioma; … thesis, investigating NSAID use and colorectal cancer …

… prevention of both colorectal cancer and glioma. The same group of authors in a following
paper [73] assessed the survival of CRC patients who used TCAs post-diagnosis: the authors …

… with shorter survival in patients with gliomas, and patients with gliomas with … antidepressant
use on the risk of glioma [85,86]. Tricyclic antidepressants (TCAs) reduce the risk of glioma …

… tricyclic antidepressant (TCA) use on the survival outcomes in patients with either glioma or
colorectal cancer… For colorectal patients, post-diagnosis TCA exposure was associated with a …

… worsen overall survival and prognosis in patients with brain … inhibitors (SSRIs), the tricyclic
antidepressants (TCA) and the … of using TCAs for patients with glioma or colorectal cancer. …

… both in the context of apoptosis and cell survival. In human … use of tricyclic antidepressants
in the treatment of glioma has … , thus inducing cell death in HM7 colon cancer cells. In addition, …

… glioma patients showed a non-significant longer survival [“… those treated post-diagnosis with
tricyclic antidepressants [208]… (longer survival if treated with a tricyclic antidepressant) would …